Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer chemotherapy can cause permanent hair loss.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Future hair cosmetics will be safer and more effective.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Menopause affects hair and skin; more research needed for treatment.

Tight hairstyles, especially on chemically treated hair, can cause reversible hair loss if caught early but may become permanent if not addressed.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

The supplement helps improve hair growth and reduce hair shedding.

Follicular Unit Extraction is a less invasive hair transplant method with potential for natural results but has challenges like longer surgery time and higher cost.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Doctors should suggest hair replacement based on personal needs and stress scalp cleanliness to avoid skin problems.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The hair serum significantly improved hair growth and reduced hair fall without causing any skin issues.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Tissue expansion is an effective treatment for certain types of hair loss, providing immediate coverage with hair-bearing skin.

PRP preservation improves hair transplant results better than saline.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.